CSF test can pick up Alzheimer's early

Analysis of the cerebrospinal fluid can detect whether a person has Alzheimer's disease before symptoms appear. Researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden, have studied biomarkers that offer more reliable diagnosis and, in the longer term, the possibility of effective new treatments.

In Alzheimer's disease, a called beta-amyloid forms between the of the brain, causing the disease's characteristic effects on memory and function. The nerve fibres also become tangled, causing certain proteins to be released into the (CSF).

Leading Alzheimer´s expert

Led by Kaj Blennow, one of the world's leading Alzheimer's experts, researchers at the University of Gothenburg's Sahlgrenska Academy have developed a way of measuring these proteins and protein fragments in the CSF so that they can be used as biomarkers – substances that reflect biological processes in the body and allow more reliable diagnoses in people with cognitive disorders.

Detect at early stage

"We found that levels of these proteins change in the CSF even with early symptoms, and we will probably be able to detect changes in the brain at a very early stage of the disease," says doctoral student Niklas Mattsson, whose thesis builds on the results.

International programme

To promote wider use of these new biomarkers, the researchers in Gothenburg have established an international quality control programme for these measurements. Besides facilitating diagnosis, the biomarkers could also be used when new drugs for Alzheimer's are tested. "We hope that a better knowledge about biomarkers will help improve the future care of neurological and psychiatric patients," says Mattsson.

More information: The thesis "CSF biomarkers reflecting beta-amyloid and axonal pathology in Alzheimer's disease and related conditions" was defended on 9 December.

add to favorites email to friend print save as pdf

Related Stories

More accurate diagnosis of Alzheimer's

Apr 19, 2011

A new study from the University of Gothenburg, Sweden, shows how analysing spinal fluid can help to detect Alzheimer's disease at an early stage. The researchers behind the study hope that their findings will contribute to ...

Biological fingerprints improve diagnosis of dementia

Oct 04, 2011

Differentiating between the various forms of dementia is crucial for initiating appropriate treatment. Researchers at the Sahlgrenska Academy have discovered that the underlying diseases leave different "fingerprints" in ...

Recommended for you

Aid group: No need to isolate staff treating Ebola

5 minutes ago

Doctors Without Borders insisted Friday, after one of its doctors who worked in Guinea came down with Ebola in New York, that quarantines of health workers returning from the hot zone are not necessary when ...

New York on alert over first Ebola case

13 minutes ago

New York went on alert Friday as authorities sought to calm fears among the city's 8.4 million residents after a doctor tested positive for Ebola.

Volunteer guidelines for clinicians in the Ebola epidemic

55 minutes ago

Disaster Medicine and Public Health Preparedness Journal has released a novel, informative article that speaks to volunteers within the Ebola epidemic. The article, contributed by a consortium of Boston-based hospitals, is ent ...

US lawmaker: New case raises questions on Ebola

1 hour ago

The new case of Ebola diagnosed in New York City has raised "even more questions about procedures in treating patients and risks to Americans," a Republican committee chairman said Friday.

User comments